CD8A and neoplasm: JOC-x is a conjugatable tumor tight junction opener, when conjugated with poly-IC, it could not only recruit and activate of CD8+ T cells by targeting DCs, but also play a tumor killing role by initiating apoptosis in tumor cells [133].